Cystatin C and aging success

Archives of Internal Medicine

Volumn 168, Issue 2, 2008, Pages 147-153

  Sarnak, Mark J ^a   Katz, Ronit ^b,c   Fried, Linda F ^d   Siscovick, David ^b,c   Kestenbaum, Brian ^c   Seliger, Stephen ^e   Rifkin, Dena ^a   Tracy, Russell ^f   Newman, Anne B ^d   Shlipak, Michael G ^g  

^a TUFTS MEDICAL CENTER   (United States)

^b Departments of Neurology and Epidemiology   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIDIABETIC AGENT; C REACTIVE PROTEIN; CYSTATIN C; HIGH DENSITY LIPOPROTEIN; INSULIN;

AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LIFESPAN; LUNG DISEASE; MALE; NEOPLASM; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PREVALENCE; PRIORITY JOURNAL;

AGED; AGING; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE;

EID: 38849134899     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2007.40     Document Type: Article

References (34)

1. Reed DM, Foley DJ, White LR, Heimovitz H, Burchfiel CM, Masaki K. Predictors of healthy aging in men with high life expectancies. Am J Public Health. 1998;88(10):1463-1468.
2. Newman AB, Arnold AM, Naydeck BL, et al; Cardiovascular Health Study Research Group. "Successful aging": effect of subclinical cardiovascular disease. Arch Intern Med. 2003;163(19):2315-2322.
3. Burke GL, Arnold AM, Bild DE, et al; CHS Collaborative Research Group. Factors associated with healthy aging: the Cardiovascular Health Study. J Am Geriatr Soc. 2001;49(3):254-262.
4. Rowe JW, Kahn RL. Human aging: usual and successful. Science. 1987;237(4811):143-149.
5. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 1976;31(2):155-163.
6. Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003;107(1):87-92.
7. Shlipak MG, Fried LF, Crump C, et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int. 2002;62(3):997-1004.
8. Use of cystatin C measurement in evaluating kidney function. Nephrology (Carlton). 2005;10(suppl 4):S157-S167.
9. Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest. 1998;58(7):585-592.
10. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function: a review. Clin Chem Lab Med. 1999;37(4):389-395.
11. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis. 2001;37(1):79-83.
12. Bökenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C: a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 1998;101(5):875-881.
13. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049-2060.
14. Sarnak MJ, Katz R, Stehman-Breen CO, et al; Cardiovascular Health Study. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142(7):497-505.
15. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3):263-276.
16. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol. 1993;3(4):358-366.
17. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999;59(1):1-8.
18. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem. 2000;37(pt 1):49-59.
19. Fitti JE, Kovar MG. The Supplement on Aging to the 1984 National Health Interview Survey. Vital Health Stat 1. 1987;(21):1-115..
20. Kuller LH, Shemanski L, Manolio T, et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. 1998;29(2):388-398.
21. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48(8):314-318.
22. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the Cardiovascular Health Cognition Study. Neuroepidemiology. 2003;22(1):13-22.
23. Collett D. Modeling Survival Data in Medical Research. Boca Raton, FL: Chapman & Hall/CRC; 1999.
24. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2)(suppl 1):S1-S266.
25. Manjunath G, Tighiouart H, Coresh J, et al. Level of kidney function as a risk factor for cardiovascular disease in the elderly. Kidney Int. 2003;63(3):1121-1129.
26. Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005;293(14):1737-1745.
27. Sarnak MJ, Levey AS, Schoolwerth AC, et al; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154-2169.
28. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol. 2001;8(3):131-136.
29. Roubenoff R, Rall LC. Humoral mediation of changing body composition during aging and chronic inflammation. Nutr Rev. 1993;51(1):1-11.
30. Cesari M, Penninx BW, Lauretani F, et al. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59(3):249-254.
31. Chaves PH, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women: should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc. 2002;50(7):1257-1264.
32. Odden MC, Whooley MA, Shlipak MG. Association of chronic kidney disease and anemia with physical capacity: the Heart and Soul Study. J Am Soc Nephrol. 2004;15(11):2908-2915.
33. Fliser D, Pacini G, Engelleiter R, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int. 1998;53(5):1343-1347.
34. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care. 2003;6(3):295-299.